Dr. Andre Rosa

Senior Scientist

Andre earned his degree in Applied Chemistry from Nova University Lisbon. In 2009, he was awarded a fellowship from the Graduate Program in Areas of Basic and Applied Biology, which enabled him to pursue a PhD at University College London. His doctoral research focused on cell shape changes during mitosis, using Drosophila as a model organism.

During his postdoctoral work at the Max-Delbrück Center, Andre's research centered on the mechanisms that regulate cell migration required to achieve a functional vascular patterning through the use of Zebrafish and organ-on-chip models.

Later, Andre joined Asgard Therapeutics as a Senior Scientist, where he contributed to the validation of their lead product, AT-108—a novel immunotherapy designed to reprogram cancer cells into dendritic cells within tumor organoids.

At MicroOrganoLab, Andre is involved in project management amd the development of immunocompetent organ-on-chip platforms, with a strong focus on cancer models.

In his free time, Andre enjoys kayaking, cycling, playing the guitar, and practicing photography.

Publications

N. Ferreira, D. Agorku, A. Rosa, J. Roosz, L. Christ, N. Anderle, A. Kulkarni, A. Hussein, S.S. Sayedipour, O.F. Luna, T. Legler, P. Ströbel, F. Albericio, L. Cruz, P. Beckhove, P. Loskill, F. Alves, M.A. Markus, F. Ramos-Gomes
Advanced Human Immune Cell-Organoid Co-Cultures for Functional Testing of Cancer Nanovaccines
Adv. Sci., 2026, in press, https://doi.org/10.1002/advs.202515199